Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial

Silk SE., Kalinga WF., Salkeld J., Mtaka IM., Ahmed S., Milando F., Diouf A., Bundi CK., Balige N., Hassan O., Mkindi CG., Rwezaula S., Athumani T., Mswata S., Lilolime NS., Simon B., Msami H., Mohamed M., David DM., Mohammed L., Nyaulingo G., Mwalimu B., Juma O., Mwamlima TG., Sasamalo IA., Mkumbange RP., Kamage JJ., Barrett JR., King LDW., Hou MM., Pulido D., Carnrot C., Lawrie AM., Cowan RE., Nugent FL., Roberts R., Cho J-S., Long CA., Nielsen CM., Miura K., Draper SJ., Olotu AI., Minassian AM.